Evaluation of resistance index of several anticancer agents on parental and resistant P-388 cell lines
- 30 April 1995
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 19 (4) , 257-261
- https://doi.org/10.1016/0145-2126(94)00157-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cellsBlood, 1992
- Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemiaBlood, 1992
- Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemiaBlood, 1991
- Morpholinyl anthracyclines: Option for reversal of anthracycline resistanceEuropean Journal of Cancer and Clinical Oncology, 1990
- Multidrug resistance and its circumventionEuropean Journal of Cancer and Clinical Oncology, 1990
- 9-Alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistanceEuropean Journal of Cancer and Clinical Oncology, 1990
- Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.Journal of Clinical Oncology, 1989
- Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistanceInternational Journal of Cancer, 1988
- Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodiesNature, 1985
- Treatment of children with refractory acute lymphocytic leukemia with vincristine and diltiazemMedical and Pediatric Oncology, 1985